Form 8-K - Current report:
SEC Accession No. 0001213900-22-020636
Filing Date
2022-04-19
Accepted
2022-04-19 17:25:20
Documents
7
Period of Report
2022-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea158617-8k_bluewater.htm 8-K 36231
2 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT, BY AND AMONG THE COMPANY AND T ea158617ex4-1_bluewater.htm EX-4.1 91176
3 FORM OF PREFERRED INVESTMENT OPTIONS, BY AND AMONG THE COMPANY AND THE HOLDERS ea158617ex4-2_bluewater.htm EX-4.2 97254
4 FORM OF WAINWRIGHT WARRANTS BY AND AMONG THE COMPANY AND H.C. WAINWRIGHT & CO., ea158617ex4-3_bluewater.htm EX-4.3 93131
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 13, 2022, BY AND AMONG ea158617ex10-1_bluewater.htm EX-10.1 203069
6 FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF APRIL 13, 2022, BY AND AMONG ea158617ex10-2_bluewater.htm EX-10.2 162712
7 PRESS RELEASE, DATED APRIL 13, 2022 ea158617ex99-1_bluewater.htm EX-99.1 9872
  Complete submission text file 0001213900-22-020636.txt   694630
Mailing Address 2041 COURTLAND AVENUE CINCINNATI OH 45212
Business Address 2041 COURTLAND AVENUE CINCINNATI OH 45212 646-303-0737
Blue Water Vaccines Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 22835708
SIC: 2834 Pharmaceutical Preparations